Gilliland Jeter Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$633K Buy
22,529
+31
+0.1% +$825 0.19% 97
2025
Q4
$560K Sell
22,498
-99
-0.4% -$2.5K 0.17% 104
2025
Q3
$576K Buy
22,597
+3,424
+18% +$84.5K 0.18% 106
2025
Q2
$465K Buy
19,173
+731
+4% +$17K 0.15% 115
2025
Q1
$467K Sell
18,442
-1,248
-6% -$32.7K 0.17% 108
2024
Q4
$522K Sell
19,690
-4,740
-19% -$129K 0.18% 109
2024
Q3
$707K Buy
24,430
+2,579
+12% +$75.2K 0.23% 88
2024
Q2
$611K Sell
21,851
-2,047
-9% -$56.4K 0.21% 96
2024
Q1
$663K Sell
23,898
-9,513
-28% -$264K 0.23% 92
2023
Q4
$962K Buy
+33,411
New +$1.01M 0.4% 70

Other funds holding PFE

Gilliland Jeter Wealth Management's PFE Position: Q1 2026 in Review

Gilliland Jeter Wealth Management increased its Pfizer (PFE) stake by 0.14% in Q1 2026, buying an estimated $825 and bringing the position to 22,529 shares worth $633K. The position accounts for 0.19% of the portfolio, ranked #97.

Gilliland Jeter Wealth Management first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $962K in Q4 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Gilliland Jeter Wealth Management held 22,529 shares of Pfizer worth $633K as of Q1 2026.
  • Gilliland Jeter Wealth Management bought 31 Pfizer shares in Q1 2026, an estimated $825.
  • Pfizer made up 0.19% of Gilliland Jeter Wealth Management's portfolio in Q1 2026, its #97 holding.
  • Gilliland Jeter Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Gilliland Jeter Wealth Management's Pfizer position peaked at $962K in Q4 2023.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Gilliland Jeter Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.